The assessment of Cyclophosphamide Chemotherapy Effect Loading-PLGA Nanoparticles Against Ovarian Cancer Cells Line (OVCAR-4 and PEO1). (2022). Journal of Pharmaceutical Negative Results, 13(1), 39-43. https://www.pnrjournal.com/index.php/home/article/view/180